Lajos Geczi
Ráth György Str. 7-9
Budapest, BU 1122, Hungary
Budapest, BU 1122, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Multicentric Comprehensive Clinical, Pathological, and Molecular Analysis of 12 Cases.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: December 17, 2025
Sustained complete remission with third-line nivolumab in advanced renal cell carcinoma: a case report.
Journal: Journal of medical case reports
Published: March 30, 2025
Comorbidities affecting abiraterone treatment in patients with metastatic castration-resistant prostate cancer: a meta- analysis
Journal: Magyar onkologia
Published: February 06, 2025
The effect of PSMA PET/CT performed in primary staging on the clinical decision
Journal: Magyar onkologia
Published: October 16, 2024
Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 Study.
Journal: Clinical genitourinary cancer
Published: July 12, 2024
Mutation frequency of homologous recombination repair genes in prostate adenocarcinomas
Journal: Magyar onkologia
Published: April 29, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.
Journal: European urology focus
Published: February 07, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 13, 2023
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study.
Journal: Cancer research communications
Published: October 24, 2023
A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients.
Journal: Frontiers in pharmacology
Published: May 10, 2023
Second and further lines treatment options for locally advanced or metastatic renal cell carcinoma
Journal: Magyar onkologia
Published: February 06, 2023
Last Updated: 09/26/2026